NCT04241718View on ClinicalTrials.gov

A Feasibility Study on Ultrafiltration and Blood Volume Measurements

NATerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 19, 2019

Primary Completion Date

December 27, 2022

Study Completion Date

December 27, 2022

Conditions
Acute Decompensated Heart FailureFluid Overload
Interventions
DEVICE

Aquadex FlexFlow System and BVA-100

Aquapheresis therapy with Aquadex FlexFlow System and Blood Volume Measurement with BVA-100

Trial Locations (1)

60540

Midwest Cardiovascular Institute, Naperville

Sponsors

Lead Sponsor

Nuwellis, Inc.

Collaborators (1)

Daxor Corporation
All Listed Sponsors
collaborator

Daxor Corporation

INDUSTRY

lead

Nuwellis, Inc.

INDUSTRY